TMCnet News
Kalderos announces expanded version of its Drug Discount Management tool Verify for more data-driven insightsCHICAGO, June 15, 2021 /PRNewswire/ -- Innovative healthcare tech company Kalderos today announced the launch of an expanded tool for drug manufacturers, designed to facilitate the company's next-generation Discount Monitoring solution that applies intelligent algorithms to claims level data. The new Verify tool has been redesigned with a clean, intuitive user interface and a unified view of discounts and rebates across programs. "We are excited to provide additional ease and increased capability to our manufacturer customers as they navigate the complexity of the drug discount process," said William Born, VP of Strategy, Manufacturer Solutions. "Kalderos is committed to providing the technological infrastructure to integrate systems, make them compatible, and ultimately make participating in all drug discount programs simpler and more efficient. Verify for Discount Monitoring is a key part of that vision." Verify's expanded capabilities include:
For drug manufacturers who are interested in learning more about how machine learning can provide an innovative path forward for compliant participation in drug discount programs such as 340B, Kalderos will host a live webinar on July 22 titled: "Operational impact from recent trends in 340B and how AI solutions can help." About Kalderos View original content to download multimedia:http://www.prnewswire.com/news-releases/kalderos-announces-expanded-version-of-its-drug-discount-management-tool-verify-for-more-data-driven-insights-301311965.html SOURCE Kalderos |